X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3455) 3455
Book Review (904) 904
Publication (186) 186
Newsletter (185) 185
Newspaper Article (108) 108
Book Chapter (81) 81
Book / eBook (43) 43
Conference Proceeding (16) 16
Magazine Article (4) 4
Trade Publication Article (2) 2
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2466) 2466
humans (2346) 2346
lymphomas (1511) 1511
male (1322) 1322
oncology (1291) 1291
female (1226) 1226
middle aged (1104) 1104
adult (1010) 1010
hematology (1001) 1001
aged (890) 890
lymphoma (837) 837
chemotherapy (828) 828
prognosis (827) 827
t cells (792) 792
cancer (782) 782
non-hodgkin's lymphomas (760) 760
pathology (620) 620
t-cell lymphoma (505) 505
care and treatment (502) 502
antineoplastic combined chemotherapy protocols - therapeutic use (486) 486
adolescent (469) 469
treatment outcome (467) 467
non-hodgkins-lymphoma (466) 466
medicine & public health (458) 458
diagnosis (435) 435
young adult (416) 416
research (412) 412
aged, 80 and over (395) 395
retrospective studies (362) 362
analysis (360) 360
epstein-barr-virus (353) 353
leukemia (349) 349
immunohistochemistry (348) 348
classification (336) 336
epstein-barr virus (331) 331
tumors (321) 321
transplantation (320) 320
b-cell lymphoma (315) 315
expression (311) 311
lymphoma, extranodal nk-t-cell - pathology (311) 311
health aspects (297) 297
lymphocytes (293) 293
t-cell (292) 292
neoplasm staging (285) 285
radiotherapy (283) 283
medical prognosis (280) 280
hemic and lymphatic diseases (258) 258
patients (258) 258
biopsy (252) 252
survival (252) 252
disease (242) 242
child (240) 240
disease-free survival (232) 232
lymphoma, t-cell - pathology (225) 225
lymphoma, extranodal nk-t-cell - therapy (224) 224
diagnosis, differential (217) 217
combined modality therapy (215) 215
killer cells, natural - pathology (207) 207
lymphoma, extranodal nk-t-cell - diagnosis (203) 203
dermatology (201) 201
nasal-type (200) 200
risk factors (198) 198
therapy (195) 195
medical research (193) 193
prognostic-factors (192) 192
immunophenotyping (190) 190
lymphoma, extranodal nk-t-cell - drug therapy (188) 188
lymphocytes t (187) 187
survival analysis (187) 187
development and progression (183) 183
survival rate (178) 178
antineoplastic agents - therapeutic use (175) 175
immunology (174) 174
nose neoplasms - pathology (172) 172
skin neoplasms - pathology (172) 172
immunotherapy (171) 171
radiation therapy (161) 161
hematology, oncology and palliative medicine (160) 160
follow-up studies (159) 159
rituximab (157) 157
animals (156) 156
gene expression (156) 156
l-asparaginase (155) 155
lymphoproliferative disorders (154) 154
skin (154) 154
apoptosis (151) 151
genetic aspects (151) 151
lymphoma, extranodal nk-t-cell - mortality (150) 150
abridged index medicus (149) 149
features (149) 149
neoplasms (149) 149
stem cells (149) 149
t cell lymphoma (149) 149
medicine, experimental (147) 147
bone marrow (141) 141
medical colleges (141) 141
case report (140) 140
fatal outcome (139) 139
follicular lymphoma (139) 139
non-hodgkin-lymphoma (139) 139
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Hospital Department (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT Schools - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3759) 3759
Chinese (42) 42
Japanese (26) 26
German (14) 14
French (12) 12
Polish (6) 6
Spanish (4) 4
Korean (3) 3
Hungarian (2) 2
Russian (2) 2
Turkish (2) 2
Manx (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 17, pp. 2437 - 2442
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 348 - 355
BACKGROUND: Extranodal natural killer/T-cell lymphoma, nasal type (ENKTL) is a distinct subtype of non-Hodgkin lymphoma in which the upper aerodigestive tract... 
oxaliplatin | gemcitabine | asparaginase | extranodal natural killer/T‐cell | progression‐free survival | progression-free survival | extranodal natural killer/T-cell | (NK)/T-CELL LYMPHOMA | T-cell | PROGNOSTIC-FACTORS | PHASE-II | EFFECTIVE SALVAGE REGIMEN | BARR-VIRUS-DNA | extranodal natural killer | ONCOLOGY | NASAL-TYPE | ACUTE LYMPHOBLASTIC-LEUKEMIA | SYSTEMIC CHEMOTHERAPY | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Aluminum Hydroxide - administration & dosage | Chemoradiotherapy | Young Adult | Organoplatinum Compounds - administration & dosage | Lymphoma, Extranodal NK-T-Cell - therapy | Adult | Female | Bentonite - administration & dosage | Neoplasm Recurrence, Local - prevention & control | Deoxycytidine - administration & dosage | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Head and Neck Neoplasms - pathology | Disease-Free Survival | Magnesium Hydroxide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, Extranodal NK-T-Cell - mortality | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Drug Combinations | Antimitotic agents | T cell lymphoma | Patient outcomes | Dosage and administration | Research | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus | Cancer
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 6, pp. 1834 - 1839
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 16, pp. 2386 - 2395
Abstract Purpose Radiation combined with chemotherapy has recently been proposed to treat patients with localised extranodal natural killer (NK)/T lymphoma... 
Hematology, Oncology and Palliative Medicine | Extranodal NK/T-cell lymphoma nasal type | Concurrent chemoradiotherapy | Multidrug resistance | Radiosensitive chemotherapy | ANGIOCENTRIC LYMPHOMA | ONCOLOGY-GROUP | NK/T-CELL LYMPHOMA | INVOLVED-FIELD RADIATION | NON-HODGKINS-LYMPHOMAS | PHASE-II | FOLLOW-UP | LUNG-CANCER | ONCOLOGY | RADIOTHERAPY | STAGE IE | Steroids - administration & dosage | Chemoradiotherapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemoradiotherapy - mortality | Male | Cytarabine - adverse effects | Young Adult | Lymphoma, Extranodal NK-T-Cell - therapy | Time Factors | Aged, 80 and over | Adult | Female | Retrospective Studies | Cranial Irradiation - mortality | Platinum Compounds - adverse effects | Steroids - adverse effects | Nose Neoplasms - pathology | Etoposide - adverse effects | Kaplan-Meier Estimate | Nose Neoplasms - therapy | Etoposide - administration & dosage | Treatment Outcome | Radiation Dosage | Cranial Irradiation - adverse effects | Remission Induction | Cytarabine - administration & dosage | Lymphoma, Extranodal NK-T-Cell - pathology | Adolescent | Lymphoma, Extranodal NK-T-Cell - mortality | Aged | Platinum Compounds - administration & dosage | Neoplasm Staging | Nose Neoplasms - mortality | Chemotherapy | Radiation | Etoposide | Lymphomas | T cells | Radiotherapy | Cancer | Index Medicus
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2009, Volume 27, Issue 35, pp. 6027 - 6032
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 1, pp. 32 - 39
Journal Article